文献速递肝病消化道肿瘤与早癌

主穹窿蛋白通过靶向干扰素调节因子2并降低p53活性促进肝细胞癌

Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity.
PubMed 文献 · Hepatology · 2020-03-23

该研究在小鼠模型中证实MVP缺失抑制二乙基亚硝胺、乙肝X蛋白和丙肝核心蛋白诱导的肝细胞癌发生,而强制表达MVP足以诱导小鼠肝细胞癌。机制上MVP通过隔离IRF2使HDM2从IRF2释放,进而泛素化降解p53。临床样本分析显示MVP上调与恶性特征及较差总生存相关。

要点

  • MVP缺失抑制DEN、HBx和HCV核心诱导的小鼠肝细胞癌发生
  • MVP通过隔离IRF2促进HDM2依赖的p53泛素化降解
  • MVP上调与慢性乙肝、肝硬化和肝细胞癌的恶性特征及不良生存相关

核心结论

  • MVP通过隔离IRF2促进HDM2依赖的p53缺失,从而促进肝细胞癌发展。

研究设计与样本

  • 小鼠模型研究:MVP缺陷抑制二乙基亚硝胺、乙肝X蛋白和丙肝核心诱导的肝细胞癌;强制MVP表达足以诱导小鼠肝细胞癌。
  • 机制研究:HDM2与IRF2或p53形成互斥复合物,MVP存在时HDM2从IRF2释放导致p53泛素化。
  • 小鼠异种移植模型显示HBV和HCV通过诱导MVP导致HDM2介导的p53缺失促进癌变。
  • 临床样本分析:慢性乙肝、肝硬化和肝细胞癌样本中MVP上调与恶性特征及较差总生存相关。

主要发现

  • MVP缺陷抑制二乙基亚硝胺、乙肝X蛋白和丙肝核心诱导的肝细胞癌发展。
  • 强制MVP表达足以诱导小鼠肝细胞癌。
  • MVP存在时HDM2从IRF2释放,导致肿瘤抑制因子p53泛素化。
  • HBV和HCV通过诱导MVP导致HDM2介导的p53缺失促进癌变。
  • 慢性乙肝、肝硬化和肝细胞癌临床样本中MVP上调与恶性特征及较差总生存相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Major vault protein (MVP) is up-regulated during infections with hepatitis B virus (HBV) and hepatitis C virus (HCV). Here, we found that MVP deficiency inhibited hepatocellular carcinoma (HCC) development induced by diethylnitrosamine, hepatitis B X protein, and HCV core. APPROACH AND RESULTS: Forced MVP expression was sufficient to induce HCC in mice. Mechanistic studies demonstrate that the ubiquitin ligase human double minute 2 (HDM2) forms mutual exclusive complexes either with interferon regulatory factor 2 (IRF2) or with p53. In the presence of MVP, HDM2 is liberated from IRF2, leading to the ubiquitination of the tumor suppressor p53. Mouse xenograft models showed that HBV and HCV promote carcinogenesis through MVP induction, resulting in a loss of p53 mediated by HDM2. Analyses of clinical samples from chronic hepatitis B, liver cirrhosis, and HCC revealed that MVP up-regulation correlates with several hallmarks of malignancy and associates with poor overall survival. CONCLUSIONS: Taken together, through the sequestration of IRF2, MVP promotes an HDM2-dependent loss of p53 that promotes HCC development.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yu H, Li M, He R, et al. Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity. Hepatology. 2020. PMID: 31758709. doi:10.1002/hep.31045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。